Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC13028 SB 415286

    3-[(3-氯-4-羟苯基)氨基]-4-(2-硝苯基)-1H-吡咯-2,5-二酮

    A selective inhibitor of GSK-3
  3. GC17990 PP 1

    蛋白磷酸酯酶-1(抗原),AGL 1872; EI 275

    PP 1是一种新型的高效、选择性Src家族酪氨酸激酶抑制剂,PP 1有效抑制Lck(IC50=5nM)和Fyn(IC50=6nM)的磷酸化来阻断T细胞受体信号通路。
  4. GC12725 VX-765

    Belnacasan; N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺; VX-765

    VX-765 是一种新开发的选择性小分子 caspase-1 抑制剂,可通过血脑屏障并在体外和体内减少炎症。

  5. GC10111 Regorafenib

    瑞戈非尼; BAY 73-4506

    Regorafenib是一种具口服活性的多激酶抑制剂,抑制VEGFR1/2/3,PDGFRβ,Kit,RET和Raf-1的IC50值分别为13/4.2/46,22,7,1.5和2.5nM。
  6. GC13163 Embelin

    恩贝酸; Embelic acid; Emberine; NSC 91874

    Embelin是一种非肽类、可穿透细胞的小分子X连锁凋亡抑制蛋白(XIAP)抑制剂,其IC₅₀值为4.1µM。
  7. GC15718 CID 2011756 An inhibitor of protein kinase D
  8. GC10816 GDC-0941

    GDC-0941

    GDC-0941是一种口服有效的I类PI3K泛抑制剂,对p110α、p110β、p110δ和p110γ的IC50值分别为3nM、33nM、3nM和75nM。
  9. GC16893 ICG 001 ICG001 是一种靶向 Wnt/β-catenin 通路的小分子抑制剂。
  10. GC12450 BI 2536

    BI-2536;BI2536

    BI 2536是一种双重Polo样激酶(PLK)/溴结构域抑制剂,在无细胞激酶实验中,BI 2536 对PLK1、PLK2和PLK3的半数抑制浓度(IC50)值分别为0.83nM、3.5nM和9.0nM。
  11. GC11247 PRIMA-1MET

    APR-246

    PRIMA-1MET是一种能够恢复肿瘤抑制功能的小分子有机化合物,主要靶向突变型p53,诱导多种癌细胞死亡。
  12. GC11065 Pifithrin-μ

    NSC 303580

    Pifithrin-μ是p53和HSP70的抑制剂。
  13. GC10896 Cyclic Pifithrin-α hydrobromide

    环状抑制剂-Α氢溴酸盐,Pifithrin-β

    A stable inhibitor of p53
  14. GC15503 NSC 687852 (b-AP15)

    b-AP15

    An inhibitor of the deubiquitinases USP14 and UCHL5
  15. GC12353 Mitomycin C

    丝裂霉素 C,Ametycine

    Mitomycin C是一种抗生素,从链霉菌(Streptomyces Caespitosus)或淡紫色链霉菌(Streptomyces Lavendulae)中分离出来。

  16. GC14321 Sal 003

    (2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺

    An inhibitor of eIF2α dephosphorylation
  17. GC12604 Fumonisin B1

    伏马菌素B1

    A mycotoxin

  18. GC12660 AZD1208

    AZD 1208;AZD-1208

    AZD1208 是一种有效、高选择性且可口服的 Pim 激酶抑制剂,对 PIM1、PIM2 和 PIM3 的 IC50 值分别为 0.4、5 和 1.9nM。
  19. GC11557 WR 1065

    硫代乙基氨基乙基胺盐酸盐

    A radioprotective agent
  20. GC13590 SJ 172550

    MDMX Inhibitor II

    A small molecule inhibitor of MDMX
  21. GC10589 RETRA hydrochloride Antitumor agent
  22. GC12086 PRIMA-1

    NSC-281668

    A re-activator of the apoptotic function of mutant p53 proteins
  23. GC12658 PhiKan 083 PhiKan 083 是一种咔唑衍生物,可与表面腔结合并稳定 Y220C(一种 p53 突变体),Kd 为 167 μM。 PhiKan 083 可用于癌症研究。
  24. GC15621 NSC 146109 hydrochloride

    XI-011

    An activator of p53
  25. GC12893 MIRA-1

    NSC 19630

    MIRA-1是一种马来酰亚胺类化合物,能够恢复突变型p53的野生型构象及功能。
  26. GC10650 HLI 373 HLI 373 是一种有效的 Hdm2 抑制剂。
  27. GC15840 CP 31398 dihydrochloride A p53 stabilizing agent
  28. GC11496 TLQP 21 TLQP 21 是一种 VGF 衍生肽,具有内分泌和内分泌特性,是一种有效的 G 蛋白偶联受体补体 3a 受体 1 (C3aR1) 激动剂(EC50:小鼠 TLQP 21\u003d10.3 μM;人 TLQP 21\u003d68.8 μM) .
  29. GC17577 NQDI 1 A selective inhibitor of ASK1
  30. GC10200 Mdivi 1

    3-(2,4-二氯-5-甲氧基苯基)-2,3-二氢-2-硫代-4(1H)-喹唑啉酮,Mitochondrial division inhibitor 1

    Mdivi-1(线粒体分裂抑制剂 1)抑制创伤性脑损伤 (TBI) 诱导的动力蛋白相关蛋白 1 (Drp1) 上调、自噬功能障碍和线粒体自噬激活。
  31. GC15865 GRI 977143 GRI 977143是一种针对溶血磷脂酸受体2(LPA2 )的非脂类激动剂,EC50值为3.3μM。
  32. GC17650 DAPK Substrate Peptide A DAPK1 peptide substrate
  33. GC11543 Cesium chloride

    氯化铯

    氯化铯是钾通道的阻滞剂。
  34. GC15571 SU 9516 A pro-apoptotic Cdk2/cyclin A inhibitor
  35. GC16938 Muristerone A

    米乐甾酮A

    An ecdysteroid receptor agonist
  36. GC15400 MIM1

    4-[[[2-(环己基亚氨基)-4-甲基-3(2H)-噻唑基]亚氨基]甲基]-1,2,3-苯三醇,Inhibitor of Mcl-1

    An Mcl-1 inhibiting molecule
  37. GC12046 iMAC2 iMAC2 是一种有效的 MAC 抑制剂,IC50 为 28 nM,LD50 为 15000 nM。
  38. GC15987 BIM, Biotinylated

    Bim peptide fragment with a biotin moiety attached

  39. GC16695 Bax inhibitor peptide, negative control Peptide inhibit Bax translocation to mitochondria
  40. GC17195 Bax inhibitor peptide V5

    BIP-V5; BAX Inhibiting Peptide V5

    A Bax inhibitor
  41. GC16023 Bax inhibitor peptide P5 Bax inhibitor
  42. GC12763 Bax channel blocker Bax 通道阻滞剂是 BAX(一种凋亡调节剂)的选择性变构抑制剂。 Bax 通道阻滞剂直接与 BAX 结合并变构抑制 BAX 活化。 Bax 通道阻滞剂具有研究由 BAX 依赖性细胞死亡介导的疾病的潜力。
  43. GC17131 Streptozocin

    链脲佐菌素; Streptozotocin; U 9889

    Streptozocin 是一种有效的 DNA 甲基化抗生素,是一种天然存在的亚硝基酰胺,在实验模型中广泛用于产生糖尿病。
  44. GC10315 Plumbagin

    白花丹素; 2-Methyljuglone

    A natural naphthoquinone
  45. GC10282 Piperlongumine

    荜茇酰胺; Piplartine

    Piperlongumine是从Piper longum L.中提取的天然生物碱化合物,具有多种药理活性,包括抗肿瘤、脂质代谢调节、抗血小板聚集和镇痛活性等。
  46. GC14860 Oncrasin 1

    1-(4-氯苄基)-1H-吲哚-3-甲醛

    An anticancer agent
  47. GC15484 Deguelin

    鱼藤素; (-)-Deguelin; (-)-cis-Deguelin

    Deguelin是四种主要天然鱼藤酮类化合物之一,从植物根部提取物中分离得到,最为人熟知的是其作为NADH:泛醌氧化还原酶(复合体I)抑制剂的作用,可导致线粒体功能的显著改变。
  48. GC17969 CHM 1

    NSC656158

    An inhibitor of tubulin polymerization
  49. GC16866 Actinomycin D

    放线菌素D,DACTINOMYCIN

    阿克替诺霉素D(也称为达克替诺霉素)是一种从链霉菌属中分离出来的天然色胺肽,含有一个杂环色团和两个五元环戊肽内酯环。
  50. GC12258 2,3-DCPE hydrochloride 2,3-DCPE 是一种促凋亡化合物,对癌细胞\u003cem\u003e相对于\u003c/em\u003e正常人细胞具有选择性
  51. GC16806 R18

    PHCVPRDLSWLDLEANMCLP

    R18 是 14-3-3 的肽拮抗剂,KD 为 70-90 nM。 R18 有效阻断 14-3-3 与激酶 Raf-1(14-3-3 的生理配体)的结合,并有效消除 14-3-3 对磷酸酶诱导的 Raf-1 失活的保护作用。

Items 2351 to 2400 of 2721 total

per page

Set Descending Direction